September 12, 2018
Low- and middle-income countries (LMICs) face a range of obstacles in healthcare including access, funding, education, and personnel. However, laboratory diagnostics including pathology are particularly challenging because of the specialized personnel, unique reagents, quality processes, and overall logistics of delivering the right diagnosis to the right patient at the right time. In this webinar, on September 12 at 1-2 PM ET, leaders from academia, the ASCP, and the CDC will discuss the challenges of laboratory diagnostics and present examples of solutions from cancer and infectious diseases. Common pitfalls and practical, sustainable solutions will be discussed.
Quentin Eichbaum, MD, PhD, MPH, MFA, MMHC, FCAP | Vanderbilt University School of Medicine: Quentin Eichbaum was born and raised in Namibia and South Africa. He initially studied law at the University of Cape Town and then completed his MD, MPH, PhD/postdoctoral studies at Harvard Medical School and the Massachusetts Institute of Technology in Boston followed by residency and fellowship training at Massachusetts General Hospital. He is currently Professor of Pathology, Microbiology and immunology and Professor of Medical Education and Administration at Vanderbilt University where he also directs the a fellowship in pathology, as well as the Pathology Program in Global Health and the Vanderbilt Pathology Education Research Group. He serves on numerous national and international global health education and pathology committees. At CUGH he chairs the Education Committee and is on the Board of Directors of Directors. He co-founded the Consortium of New Sub-Sahara African Medical Schools (CONSAMS) and is involved in health professional education and clinical medicine in several African countries.
Kevin Karem, PhD | Centers for Disease Control (CDC): Dr. Karem is the Associate Director for Laboratory Science in the CDCs Center for Global Health. He’s held positions as scientific leader, team leader, branch chief and associate director; and in the private sector as scientist and consultant. His experiences include leadership and support to global including the WHO and PAHO. In 2015, he provided leadership in laboratory response to the W. Africa Ebola outbreak, and has worked in the America’s for laboratory capacity building during the Zika virus outbreak. Dr. Karem is dedicated to advancing science through implementation and innovation for, and fostering relationships for improved performance.
Dan Milner, MD, MSc | American Society for Clinical Pathology (ASCP) : Dr. Dan Milner is the Chief Medical Officer of the American Society for Clinical Pathology where he handles all medical affairs and oversees the work of the Center for Global Health including all PEPFAR activities, the Partners for Cancer Diagnosis and Treatment Initiative, and collaborative work with more than 15 international partners. Dr. Milner was previously at Harvard as an infectious disease pathologist and microbiologist and is the author of over 125 manuscripts and publications.